Pharmacology for Nurses · Psychopharmacologic Drugs

Mood Stabilizers

9 min read
Drug classes and mechanisms only; no doses, schedules, or administration recommendations are included. Verify all clinical decisions, therapeutic levels, and monitoring schedules against current references, the institutional formulary, and prescriber orders.
Want it in plain words first? Jump to Eli explains — the same idea, no jargon.
On this page 9 sections
  1. In 30 seconds
  2. Why this matters
  3. The college version
  4. Eli explains
  5. Worked example
  6. Key takeaway
  7. Check yourself
  8. Study tools
  9. Sources & references

In 30 seconds

Mood stabilizers are drugs used to treat , a condition defined by swings between manic or hypomanic episodes (elevated or irritable mood, decreased need for sleep, pressured speech, risky behavior) and depressive episodes. The goal is not to eliminate all mood variation but to keep the person's mood within a functional range — preventing manic and depressive episodes and reducing their severity when they occur. "Mood stabilizer" is a clinical category rather than a single mechanism: the drugs that fill the role work in very different ways. The core agents are lithium and certain anticonvulsant drugs used for mood purposes — valproate (divalproex), lamotrigine, and carbamazepine — with atypical antipsychotics (e.g., aripiprazole, olanzapine, quetiapine, lurasidone) frequently used as adjuncts or monotherapy depending on the phase of illness. What unites them is a requirement for careful monitoring: lithium is famous for its narrow , valproate and carbamazepine demand liver, blood, and interaction surveillance, and lamotrigine requires slow titration to avoid a severe rash. For nurses, mood stabilizers are the class where , medication reconciliation, and adherence teaching are most visibly central to safe care.

Why this matters

Bipolar disorder is a lifelong condition, and mood stabilizers are typically taken for years; an untreated can destroy relationships, finances, and employment, and bipolar depression carries a substantial suicide risk. These drugs are also among the most dangerous to get wrong: can be fatal, and its risk rises with dehydration, kidney impairment, or the addition of common drugs such as NSAIDs, ACE inhibitors, or diuretics that reduce lithium excretion. Valproate carries risks of liver injury, pancreatitis, and birth defects; carbamazepine is a powerful enzyme inducer that changes the levels of many other drugs; and lamotrigine's dose must climb slowly or the person risks a severe, potentially life-threatening rash. The nurse is the professional who verifies serum levels, reconciles interacting drugs, teaches people to maintain consistent salt and fluid intake on lithium, and watches for early toxicity signs — skills that directly prevent harm.

The college version

Core Concepts

Lithium: the classic stabilizer with a narrow window

Lithium has been used for decades and remains a first-line treatment for bipolar disorder, particularly for preventing manic episodes and reducing suicide risk. Its mechanism is not fully understood — leading theories involve effects on inositol signaling, neurotransmitter release, and neuroprotective gene expression — but its clinical value is well established. The critical concept is the narrow therapeutic index: the range between effective and toxic serum levels is small, so levels are measured periodically and the dose adjusted accordingly. Lithium is excreted by the kidneys and follows sodium: if sodium drops (dehydration, low-salt diet, diuretics) the kidneys retain lithium and levels can climb into toxicity. Early toxicity shows as fine tremor, nausea, diarrhea, and lethargy; advanced toxicity includes coarse tremor, slurred speech, ataxia, confusion, and seizures — a medical emergency. Long-term use requires monitoring of thyroid (hypothyroidism is common) and kidney function, and lithium is avoided or managed very cautiously in pregnancy because of teratogenic risk — all decisions and monitoring schedules follow current references and prescriber orders.

Valproate: broad-spectrum but organ-heavy

Valproate (as divalproex) is an anticonvulsant with mood-stabilizing effects, used especially for acute mania. It enhances GABA-mediated inhibition and affects other signaling pathways. Its monitoring demands are substantial: liver function (risk of hepatotoxicity), platelet counts (it can lower platelets), and awareness of pancreatitis risk. It is a strong , associated with neural tube defects and developmental concerns, so pregnancy prevention and counseling are essential in people of childbearing potential. Because valproate inhibits drug-metabolizing enzymes, it can raise levels of other medications — a reconciliation point whenever a person on valproate starts a new drug.

Lamotrigine: the maintenance agent with a titration rule

Lamotrigine is an anticonvulsant most valued in bipolar disorder for preventing depressive episodes; it is less effective for acute mania. Its distinctive risk is a serious rash, including , which is why the dose must be titrated slowly and why any new rash in the first weeks of therapy warrants immediate medical attention. Rash risk also rises when lamotrigine is combined with valproate (which raises lamotrigine levels), so combination regimens require particular vigilance.

Carbamazepine: the interaction hub

Carbamazepine is an anticonvulsant used for acute mania and maintenance. Its defining feature is : it accelerates the metabolism of many drugs (including oral contraceptives, warfarin, and many psychotropics), lowering their levels and effectiveness — and it induces its own metabolism over time. It also carries risks of aplastic anemia/agranulocytosis, hyponatremia (from SIADH-like effects), and numerous drug interactions; monitoring includes blood counts, liver function, and levels.

Atypical antipsychotics and the phase-based plan

Atypical antipsychotics (e.g., aripiprazole, olanzapine, quetiapine, lurasidone) are used across the bipolar spectrum: some are approved for acute mania, some for bipolar depression, and several for maintenance. Their mechanisms (D2 modulation with 5-HT2A antagonism or partial agonism) and their metabolic, movement, and QT monitoring needs overlap with those discussed in the antipsychotics topic. Treatment plans in bipolar disorder are phase-based: the drug (or combination) chosen for an acute manic episode may differ from the maintenance regimen, and the nurse must know what the current phase is and what each drug is expected to do in it.

The nursing role: levels, labs, and life teaching

Mood-stabilizer nursing care clusters around four tasks: therapeutic drug monitoring (drawing levels at the right time relative to the dose, per orders, and knowing the target range), organ surveillance (thyroid, kidney, liver, blood counts, and metabolic panels on their scheduled intervals), interaction and adherence teaching (lithium's sodium relationship, carbamazepine's enzyme induction, valproate's teratogenicity, lamotrigine's rash rule), and symptom and toxicity vigilance (tremor, ataxia, GI upset, rash, mood change). Person-first, recovery-oriented language applies throughout — the nurse partners with a person living with bipolar disorder to keep them safe and functional. All levels, labs, and drug decisions follow current guidelines, the formulary, and prescriber orders — verify against current references.

Common Confusions

Do Not ConfuseWithDifference
Lithium tremor (early toxicity)Essential tremor or anxietyFine tremor with nausea/lethargy at a higher level is early lithium toxicity — check the level rather than dismissing it
Lithium toxicitySerotonin syndromeLithium toxicity is elevated lithium level (tremor, ataxia, confusion, seizures) from dosing, renal, or interaction causes; serotonin syndrome is serotonin excess from serotonergic drugs
ValproateValproate plus lamotrigineValproate raises lamotrigine levels, increasing rash risk — combination regimens need slower lamotrigine titration and closer vigilance
CarbamazepineOxcarbazepineCarbamazepine is a strong enzyme inducer with many interactions; oxcarbazepine has fewer interactions and different monitoring
Mood stabilizerAntidepressantMood stabilizers prevent manic and depressive swings in bipolar disorder; antidepressants treat depression — using an antidepressant alone in bipolar disorder can risk triggering mania
Drug level drawn anytimeLevel drawn at the right timeLevels must be drawn per protocol relative to the dose to be interpretable — timing is part of the nurse's responsibility
Acute mania drugMaintenance drugWhat works to break acute mania (e.g., valproate, antipsychotics) may differ from the maintenance regimen that prevents future episodes — know which phase the person is in
Eli, the EliExplains learning guide

Eli explains

The same idea, in plain words

Explain it like I’m 10

Bipolar disorder is like a thermostat that swings too hot and too cold. Mood stabilizers are like a thermostat repair: they keep the temperature in a comfortable middle range instead of letting it swing to extremes. Lithium, the oldest tool for this, is like a medicine that must be measured exactly — a little too much is poisonous and a little too little doesn't work — so the nurse checks the "dose meter" (blood level) regularly and teaches the person to keep drinking and eating normally, because the medicine's level depends on the body's water and salt.

Worked example

A level, a new prescription, and a teachable moment. A person stabilized on lithium for two years comes to the clinic after starting an NSAID for joint pain, bought over the counter. The nurse reviews the medication list and flags the interaction: NSAIDs can reduce lithium excretion, raising the serum level. The provider orders a lithium level, which comes back above the person's usual range with the person reporting mild tremor and nausea — early toxicity. The plan: hold the NSAID, recheck the level, and review fluids. The nurse teaches the person that lithium follows sodium, so dehydration from heat, exercise, or illness can push levels up, and that all new medicines — including over-the-counter ones — must be checked first. The person leaves with a written plan and a follow-up appointment for a repeat level and thyroid labs. The scenario shows the everyday work of mood-stabilizer nursing: it is not just giving the drug but managing the level, the interactions, and the person's understanding of their own treatment.

Key takeaways

  • Mood stabilizers treat bipolar disorder — the goal is preventing manic and depressive episodes, not flattening all mood.
  • Lithium has a narrow therapeutic index; toxicity (tremor, ataxia, confusion, seizures) is an emergency. Levels rise with dehydration, low sodium, and NSAIDs/ACE inhibitors/diuretics — teach consistent fluid and salt intake and reconcile interacting drugs.
  • Long-term lithium care includes thyroid and kidney monitoring; lithium is a teratogen and requires pregnancy planning.
  • Valproate needs liver and platelet monitoring, carries pancreatitis and teratogen risks, and raises levels of other drugs.
  • Lamotrigine prevents depressive episodes; slow titration prevents a serious rash (Stevens-Johnson syndrome) — any early rash is a red flag.
  • Carbamazepine is an enzyme inducer — it lowers levels of oral contraceptives, warfarin, and many other drugs — and needs blood count and liver monitoring.
  • Atypical antipsychotics are used across phases (mania, depression, maintenance) with their own metabolic and movement monitoring.
  • The nurse's core functions: therapeutic drug levels, scheduled labs, interaction checks, and teaching people to recognize early toxicity.

Check yourself

5 review questions from the chapter. Try each one, then open the answer.

  1. Why does lithium toxicity risk increase if a person becomes dehydrated or starts an NSAID?

    Show answer

    Lithium is excreted by the kidneys and handled like sodium. Dehydration or low sodium makes the kidneys retain lithium, and NSAIDs (and ACE inhibitors, diuretics) reduce lithium excretion — so serum levels can climb into the toxic range.

  2. What is the distinctive risk of lamotrigine, and what rule reduces it?

    Show answer

    A serious, potentially life-threatening rash (Stevens-Johnson syndrome). The risk is reduced by slow dose titration — and any new rash early in treatment warrants immediate medical attention.

  3. Why is carbamazepine's enzyme induction a safety problem for a person also taking an oral contraceptive or warfarin?

    Show answer

    Carbamazepine induces drug-metabolizing enzymes, accelerating the breakdown of oral contraceptives and warfarin — lowering their levels and effectiveness, which risks unintended pregnancy or inadequate anticoagulation.

  4. What early signs of lithium toxicity should the nurse teach the person to report?

    Show answer

    Fine tremor, nausea, diarrhea, and lethargy are early signs; coarse tremor, slurred speech, ataxia, and confusion signal advanced toxicity and require urgent care.

  5. Why is a mood stabilizer, rather than an antidepressant alone, the foundation of bipolar disorder treatment?

    Show answer

    Antidepressants alone can trigger a switch into mania in bipolar disorder. Mood stabilizers prevent both poles of the illness, so they form the treatment foundation, with phase-specific drugs added as needed.

Keep learning

Ready to build on this? Continue to the next lesson.

Study tools & related lessonsKey vocabulary · Related

Key vocabulary

Bipolar disorder
A mood disorder with manic/hypomanic and depressive episodes
Manic episode
A period of elevated/irritable mood, decreased sleep need, and risky behavior
Therapeutic index
The ratio between an effective dose and a toxic dose
Therapeutic drug monitoring
Measuring serum drug levels to keep them in the effective, safe range
Lithium toxicity
Poisoning from excessive lithium levels: tremor, ataxia, confusion, seizures
Enzyme induction
A drug speeding up the metabolism of other drugs (carbamazepine)
Teratogen
A substance that can cause birth defects during pregnancy
Stevens-Johnson syndrome
A severe, life-threatening rash reaction (lamotrigine risk)

Sources & references

  1. openstax.org — Pharmacology

This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.

Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.